Evidence map›Paper›PMID 35067925›Full record

ArticleCancer2022

Impact of the COVID-19 pandemic on pediatric oncology providers globally: A mixed-methods study.

Elizabeth R Sniderman, Dylan E Graetz, Asya Agulnik, Radhikesh Ranadive, Yuvanesh Vedaraju, Yichen Chen, Meenakshi Devidas, Guillermo L Chantada, Laila Hessissen, Rashmi Dalvi and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 6 countries.

Elizabeth R SnidermanDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-6004-6068
Dylan E GraetzDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-4541-6910
Asya AgulnikDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-8932-8181
Radhikesh RanadiveDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.
Yuvanesh VedarajuDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.
Yichen ChenDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.
Meenakshi DevidasDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.
Guillermo L ChantadaDepartment of Pediatric Hematology and Oncology, Fundacion Perez Scremini-Hospital Pereira Rossell, Montevideo, Uruguay.ORCID 0000-0002-9375-9336
Laila HessissenDepartment of Pediatric Hematology and Oncology, Mohammed V University, Rabat, Morocco.
Rashmi DalviDepartment of Pediatrics, Bombay Hospital Institute of Medical Sciences, Bombay, India.
Kathy Pritchard-JonesGreat Ormond Street Institute of Child Health, University College London, London, England.ORCID 0000-0002-2384-9475
Carlos Rodriguez-GalindoDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.
Daniel C MoreiraDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-4082-156X
St. Jude Children's Research Hospital · USBombay Hospital · INGreat Ormond Street Hospital · GBHospital Sant Joan de Déu Barcelona · ESMohammed V University · MA

Funding

American Lebanese Syrian Associated Charities
6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) disrupted pediatric oncology care globally, increasing demands on health care providers (HCPs) who adapted to continue care. This study sought to characterize the pandemic's impact on pediatric oncology HCPs worldwide.

methodsA 60-item survey focused on changes to clinical care, resources, and effects on clinicians. A diverse subgroup of institutions was purposefully selected for focus groups that explored teamwork, communication, and changes to care delivery.

resultsThe survey included 311 responses from 213 institutions representing 79 countries. Sixteen institutions participated in 19 multidisciplinary focus groups in 8 languages. Decreased clinical staff availability was cited by 51% of institutions as a major impact. Staffing modifications included decreased provider availability (66% of institutions), roles or responsibility changes, and transfer outside the specialty. Physical effects included frequent COVID-19 illness; 8% of respondents reported HCP deaths. Fifty percent of providers did not have the necessary personal protective equipment. HCPs also experienced psychological distress and financial concerns. Findings indicated more frequent impact on nurses than other providers. Impacts were described across all hospital resource levels, with staffing modifications more frequent in countries with higher COVID-19 incidence (P < .001) and mortality rate (P = .004). Focus groups revealed negative impacts were stabilized by increased teamwork, communication, contributions outside usual roles, policies aimed at optimizing safety, and feeling that they were contributing.

conclusionsCOVID-19 had a profound impact on the pediatric oncology workforce, creating challenging modifications to staffing and resulting in physical, psychological, and financial distress. Despite these challenges, HCPs caring for children with cancer came together to continue to provide high-quality care.

Indexed as

COVID-19NeoplasmsChildHumansPandemicsPersonal Protective EquipmentSARS-CoV-2coronavirus disease 2019 (COVID-19)delivery of health careglobalhealth care personnelpediatric oncologyworkforce

Identifiers

PMID35067925
PMCPMC9015299
OpenAlexW4206951219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.